caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952350563

Daniel EslingerPMHNP/ARNP

Nurse PractitionerWalla Walla, WAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
PRESCRIBING · PART D · 2024
Total Rx claims
3,250
Beneficiaries
—
Total drug cost
$401K
Distinct drugs
47
Brand share
23.1%
Top prescribed drugs
Gabapentin329 claims
Duloxetine Hcl314 claims
Bupropion Hcl290 claims
Ziprasidone Hcl214 claims
Quetiapine Fumarate187 claims
REFERRAL NETWORK

Where Daniel Eslinger's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PHARMACOGENETICS DIAGNOSTIC LABORATORY LLC44144
PROVIDENCE HEALTH & SERVICES - WASHINGTON2050
HOLMES, CYNTHIA1242
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
170
Unique beneficiaries
—
Total services
747
Distinct HCPCS
2
Medicare payment
$39K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 3,734 Nurse Practitioner providers in WA — top quintile (cohort median 228).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.